logo

For the Inventor, By the Inventor

Palatine, IL, United States of America

Stephen T Gately

This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignees: G.d. Searle & Company, Northwestern University, Pfizer Corporation. Active years: 1998-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen T Gately. Retrieved from https://idiyas.com/inventor/stephen-t-gately

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 50.0

Average Co-Inventor Count = 4.5

ph-index = 6

Forward Citations = 187(Granted Patents)


Company Filing History:

goldMedal3 out of 1,323 
 
G.d. Searle & Company
 patents
silverMedal2 out of 2,233 
 
Northwestern University
 patents
bronzeMedal1 out of 4,492 
 
Pfizer Corporation
 patents

Years Active: 1998-2005

Loading Chart...
6 patents (USPTO):Explore Patents
1. 6916800 - Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent (2005-07-12),
2. 6858598 - Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia (2005-02-22),
3. 6833373 - Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia (2004-12-21),
4. 6689787 - Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia (2004-02-10),
5. 6576609 - Methods and compositions for generating angiostatin (2003-06-10),
6. 5801012 - Methods and compositions for generating angiostatin (1998-09-01),

Title: The Innovations of Stephen T. Gately

Introduction

Stephen T. Gately is a notable inventor based in Palatine, IL (US). He has made significant contributions to the field of medicine, particularly in the treatment of neoplasia disorders. With a total of 6 patents to his name, Gately's work has the potential to impact therapeutic strategies significantly.

Latest Patents

Gately's latest patents include innovative methods for treating neoplasia. One of his notable inventions is a combination therapy that includes a matrix metalloproteinase inhibitor and an antineoplastic agent. This invention provides methods to treat or prevent neoplasia disorders in mammals. Another significant patent details a method of using a matrix metalloproteinase inhibitor alongside one or more antineoplastic agents, such as irinotecan and topotecan, as a combination therapy for neoplasia treatment.

Career Highlights

Throughout his career, Gately has worked with prominent organizations, including G.D. Searle & Company and Northwestern University. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Gately has collaborated with several professionals in his field, including John Patrick McKearn and Gary B. Gordon. These collaborations have likely enriched his research and development efforts, leading to the successful patents he holds today.

Conclusion

Stephen T. Gately's contributions to the field of medicine through his patents demonstrate his commitment to innovation and improving treatment options for neoplasia disorders. His work continues to inspire advancements in therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…